×
About 665 results

ALLMedicine™ Anaplastic Thyroid Carcinoma Center

Research & Reviews  253 results

Can TP53-mutant follicular adenoma be a precursor of anaplastic thyroid carcinoma?
https://doi.org/10.1530/ERC-21-0095
Endocrine-related Cancer; Nikitski AV, Nikiforova MN et. al.

Jul 16th, 2021 - Mutations of the TP53 tumor suppressor gene are highly prevalent in thyroid anaplastic carcinomas (AC) but are also reported in some well-differentiated cancers and even benign adenomas. The natural history of TP53-mutant adenomas, and whether the...

Anaplastic Thyroid Carcinoma.
https://doi.org/10.1016/j.mayocp.2021.05.023
Mayo Clinic Proceedings; Erickson LA

Jul 6th, 2021 - Anaplastic Thyroid Carcinoma.|2021|Erickson LA,|methods,classification,pathology,surgery,pathology,classification,pathology,surgery,methods,

A High-Throughput Approach to Identify Effective Systemic Agents for the Treatment of A...
https://doi.org/10.1210/clinem/dgab424
The Journal of Clinical Endocrinology and Metabolism; Henderson YC, Mohamed ASR et. al.

Jun 14th, 2021 - Despite the use of aggressive multimodality treatment, most anaplastic thyroid carcinoma (ATC) patients die within a year of diagnosis. Although the combination of BRAF and MEK inhibitors has recently been approved for use in BRAF-mutated ATC, the...

Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
https://doi.org/10.1089/thy.2020.0962
Thyroid : Official Journal of the American Thyroid Associ... Lubitz CC, Sadow PM et. al.

Apr 17th, 2021 - Background: Thyroid cancer is a common malignancy whose detection has increased significantly in past decades. Most of the increased incidence is due to detection of early well-differentiated thyroid cancer, but the incidence of more advanced thyr...

see more →

Guidelines  3 results

The revised clinical practice guidelines on the management of thyroid tumors by the Jap...
https://doi.org/10.1507/endocrj.EJ20-0025
Endocrine Journal; Ito Y, Onoda N et. al.

Apr 10th, 2020 - The Japan Associations of Endocrine Surgeons has developed the revised version of the Clinical Practice Guidelines for Thyroid Tumors. This article describes the guidelines translated into English for the 35 clinical questions relevant to the ther...

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
https://doi.org/10.6004/jnccn.2018.0089
Journal of the National Comprehensive Cancer Network : JN... Haddad RI, Nasr C et. al.

Dec 14th, 2018 - The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights summa...

Anaplastic Thyroid Carcinoma, Version 2.2015.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986600
Journal of the National Comprehensive Cancer Network : JN... Haddad RI, Lydiatt WM et. al.

Sep 12th, 2015 - This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were made to the systemic therapy recommendations for the 2015 update. Dosage...

see more →

Clinicaltrials.gov  3 results

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients
https://clinicaltrials.gov/ct2/show/NCT02114658

Aug 3rd, 2017 - The objectives of this study are to evaluate safety, efficacy and pharmacokinetics of sorafenib for the treatment of Japanese patients with anaplastic thyroid carcinoma (ATC) or locally advanced or metastatic medullary thyroid carcinoma (MTC).

Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
https://clinicaltrials.gov/ct2/show/NCT00507429

Jun 9th, 2014 - Anaplastic thyroid carcinoma (ATC) is a high-grade neoplasm, characterized by an aggressive clinical course with brief survival, and refractoriness to currently available local and systemic modalities of treatment. There is no standard therapy for...

Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma
https://clinicaltrials.gov/ct2/show/NCT00115739

Apr 21st, 2014 - Anaplastic thyroid carcinomas (ATC) are high grade neoplasms, which account for approximately 2% to 5% of primary malignant thyroid tumors but more than 50% of thyroid cancer deaths. Because therapies for anaplastic thyroid carcinoma are very limi...

see more →

News  7 results

Targeted Treatment Tied to Longer Survival in Patients With Anaplastic Thyroid Cancer
https://www.medscape.com/viewarticle/936044

Aug 21st, 2020 - NEW YORK (Reuters Health) - With the introduction of targeted treatments for anaplastic thyroid carcinoma, patients have seen significant improvements in survival, according to a new report. "Over the last 5 years, a greater understanding of the m...

Targeted Treatment Tied to Longer Survival in Patients With Anaplastic Thyroid Cancer
https://www.staging.medscape.com/viewarticle/936044

Aug 21st, 2020 - NEW YORK (Reuters Health) - With the introduction of targeted treatments for anaplastic thyroid carcinoma, patients have seen significant improvements in survival, according to a new report. "Over the last 5 years, a greater understanding of the m...

Lichenoid dermatitis with mycosis fungoides features linked to checkpoint inhibitor therapy
https://www.mdedge.com/hematology-oncology/article/205419/immunotherapy/lichenoid-dermatitis-mycosis-fungoides-features?channel=39313
Bianca Nogrady

Jul 28th, 2019 - A patient treated with immune checkpoint inhibitor therapy for thyroid carcinoma presented with lichenoid dermatitis that resembled mycosis fungoides and also showed with monoclonal T-cell receptor gene rearrangement. A case report published in th.

Aggressive Approach to Anaplastic Thyroid Cancer Shows Benefit
https://www.medscape.com/viewarticle/852901

Oct 20th, 2015 - ORLANDO, Florida — Survival rates of the rare anaplastic thyroid carcinoma, which has a very poor prognosis, show significant improvement when patients are treated with an aggressive combined-modality therapy, although the toxicities associated wi...

Aggressive Approach to Anaplastic Thyroid Cancer Shows Benefit
https://www.staging.medscape.com/viewarticle/852901

Oct 20th, 2015 - ORLANDO, Florida — Survival rates of the rare anaplastic thyroid carcinoma, which has a very poor prognosis, show significant improvement when patients are treated with an aggressive combined-modality therapy, although the toxicities associated wi...

see more →